Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 4 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Results 1 - 20 of 2142 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar Fabuloso (57.43) Submitted: 7/28/2014 9:12:28 PM : Outperform Start Price: $102.45 JNJ Score: +0.58

Great company !

Recs

0
Member Avatar MidAtlanticDad (58.07) Submitted: 7/17/2014 12:58:13 AM : Outperform Start Price: $101.90 JNJ Score: +0.71

Not cheap but just awesome.

Recs

0
Member Avatar calguy489 (< 20) Submitted: 7/8/2014 5:09:41 PM : Outperform Start Price: $106.00 JNJ Score: -3.43

Great company

Recs

1
Member Avatar TMFbelle (37.50) Submitted: 7/2/2014 9:50:32 AM : Outperform Start Price: $105.38 JNJ Score: -2.66

A stock which I feel should be a staple in every dividend/value investor portfolio. The quality of this company has stood the test of time and they continue to remain relevant and successful via strategies that strengthen it's ongoing competitive advantage.

The company is composed of three segments: consumer, pharma, and medical devices & diagnosis. The diversification within its portfolio of segments and well known and trusted brands allow the company an extra edge within its industry.

Despite recalls or issues that come up (as it is the norm is all major corporations) JNJ has shown it is capable not only to overcome but also to succeed.

I am long on JNJ 5 years and beyond.

Recs

1
Member Avatar NuclearSolutions (28.02) Submitted: 6/8/2014 7:59:38 AM : Outperform Start Price: $103.07 JNJ Score: -1.42

Medical Supplies for the World. 64 to 103 in 6 months

Recs

0
Member Avatar afewgoodstocks14 (39.21) Submitted: 5/23/2014 1:12:37 PM : Outperform Start Price: $86.93 JNJ Score: +6.47

Div. (Yield) $2.80 (2.8%)

Recs

0
Member Avatar bingcroz (< 20) Submitted: 5/22/2014 10:29:30 AM : Outperform Start Price: $100.43 JNJ Score: -1.97

Management, products

Recs

0
Member Avatar Rushwind (< 20) Submitted: 5/20/2014 8:09:58 PM : Outperform Start Price: $99.90 JNJ Score: -2.15

You'll have a hard time not finding a Johnson & Johnson product in your home, and the high dividend yield makes it easier for this stock to beat the average.

Recs

0
Member Avatar DCUDFlyer (43.28) Submitted: 5/19/2014 2:22:51 PM : Underperform Start Price: $99.69 JNJ Score: +1.58

Very short term bear pick (RL holding). Nice gains lately but expecting a slower climb the next few months.

Recs

0
Member Avatar Miketmah (58.61) Submitted: 4/16/2014 7:33:43 PM : Outperform Start Price: $98.01 JNJ Score: -1.43

A strong company in a tough market

Recs

0
Member Avatar TMFJoeFriday (43.72) Submitted: 3/24/2014 11:54:02 AM : Outperform Start Price: $94.18 JNJ Score: +2.27

A great dividend stock, bulletproof against negative headlines due to its massive diversity. P/E looks a little expensive for the company historically at the moment, but then again, so does the rest of the market. A great stable long-term performer, I think it can outperform the broader market.

Recs

0
Member Avatar moonlightsail (< 20) Submitted: 3/24/2014 6:15:30 AM : Outperform Start Price: $94.64 JNJ Score: +2.76

A defensive healthcare stock that has been around for a while and the dividend is good.

Recs

0
Member Avatar HayZeus (41.69) Submitted: 2/11/2014 4:37:30 PM : Outperform Start Price: $91.65 JNJ Score: +3.62

Band Aides Rule

Recs

0
Member Avatar rocker20 (41.46) Submitted: 2/11/2014 10:08:17 AM : Outperform Start Price: $90.48 JNJ Score: +4.06

Long history of dividends. Good products

Recs

0
Member Avatar ClimberMel (36.66) Submitted: 2/4/2014 11:21:08 AM : Outperform Start Price: $85.42 JNJ Score: +7.29

JNJ has always been a great performer. It has dropped much more than what I feel was justified. I've foolishly used this as a buying opportunity!

Recs

0
Member Avatar Golfer1 (25.02) Submitted: 2/3/2014 3:49:48 PM : Outperform Start Price: $85.60 JNJ Score: +6.48

Johnson and Johnson has taken a recent fall on the Stock Market, but will take a turn for the better and recover over the coming years with new and improved products.

Recs

0
Member Avatar kpruhs (< 20) Submitted: 12/20/2013 4:19:49 PM : Outperform Start Price: $91.26 JNJ Score: +4.19

JNJ has done so many things right for so many years that it will take more than a "great recession" to knock it out profitability. It falls in an elite class of companies that, while not invincible, will maintain market share, maintain reasonable dividends, and continue to fund R&D for expansion and growth.

While nothing in financial world is a sure-thing (AIG, Bear-Sterns, JPMorgan, etc.), in unsure financial times JNJ, PG, GE, MMM and their elite class of corporations are hard to bet against.

Recs

0
Member Avatar HealthyMoney (< 20) Submitted: 10/25/2013 12:12:18 PM : Outperform Start Price: $90.12 JNJ Score: +1.41

This conglomerate has diverse revenue streams, but will provide huge growth with its revamped pharmaceutical division.

Recs

0
Member Avatar BaseBawl (23.53) Submitted: 10/17/2013 2:57:01 PM : Outperform Start Price: $89.73 JNJ Score: +0.13

Dividend Growers.

Recs

0
Member Avatar rgofoolishdoc (53.80) Submitted: 10/9/2013 7:55:55 PM : Outperform Start Price: $84.91 JNJ Score: +2.85

Well diversified health care company will benefit from the ACA over the next 10 years

Featured Broker Partners


Advertisement